Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

MicroRNAs and other biomarkers of atrial fibrillation in ischemic stroke patients

P. Janský, V. Kaplan, T. Šrámková, F. Kolman, P. Kloudová, K. Benešová, A. Olšerová, P. Kešnerová, H. Magerová, V. Šulc, H. Halmová, S. Kmetonyová, J. Paulasová-Schwabová, I. Šarbochová, V. Maťoška, A. Tomek

. 2024 ; 103 (43) : e40165. [pub] 20241025

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003793

Grantová podpora
project No. 618217 Charles University Grant Agency (GA UK),

This study aimed to evaluate the ability of selected microRNAs as biomarkers of atrial fibrillation (AF) in ischemic stroke patients in comparison with other established biochemical biomarkers. A prospective case-control study of consecutive ischemic stroke patients with AF admitted to a comprehensive stroke center was conducted. The control group consisted of patients with ischemic stroke with no AF detected on prolonged (at least 3 weeks) Holter ECG monitoring. As potential biomarkers of AF, we analyzed the plasma levels of microRNAs (miR-21, miR-29b, miR-133b, miR-142-5p, miR-150, miR-499, and miR-223-3p) and 13 biochemical biomarkers at admission. The predictive accuracy of biomarkers was assessed by calculating the area under the receiver operating characteristic curve. The data of 117 patients were analyzed (61 with AF, 56 with no AF, 46% men, median age 73 years, median National Institutes of Health Stroke Scale 6). Biochemical biomarkers (N-terminal pro-B-type natriuretic peptide [NT-proBNP], high-sensitivity cardiac troponin I, fibrinogen, C-reactive protein, eGFR, and total triglycerides) were significantly associated with AF. NT-proBNP had the best diagnostic performance for AF with area under the receiver operating characteristic curve 0.92 (95%, CI 0.86-0.98); a cutoff value of >528 ng/L had a sensitivity of 79% and a specificity of 97%. None of the other biomarkers, including microRNAs, was associated with AF. Conventional biochemical biomarkers (NT-proBNP, high-sensitivity cardiac troponin I, fibrinogen, C-reactive protein, eGFR, and triglycerides), but not microRNAs (miR-21, miR-29b, miR-133b, miR-142-5p, miR-150, miR-499, and miR-223-3p) were significantly associated with AF in our ischemic stroke cohort.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003793
003      
CZ-PrNML
005      
20250206104716.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MD.0000000000040165 $2 doi
035    __
$a (PubMed)39470526
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Janský, Petr $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000331590958
245    10
$a MicroRNAs and other biomarkers of atrial fibrillation in ischemic stroke patients / $c P. Janský, V. Kaplan, T. Šrámková, F. Kolman, P. Kloudová, K. Benešová, A. Olšerová, P. Kešnerová, H. Magerová, V. Šulc, H. Halmová, S. Kmetonyová, J. Paulasová-Schwabová, I. Šarbochová, V. Maťoška, A. Tomek
520    9_
$a This study aimed to evaluate the ability of selected microRNAs as biomarkers of atrial fibrillation (AF) in ischemic stroke patients in comparison with other established biochemical biomarkers. A prospective case-control study of consecutive ischemic stroke patients with AF admitted to a comprehensive stroke center was conducted. The control group consisted of patients with ischemic stroke with no AF detected on prolonged (at least 3 weeks) Holter ECG monitoring. As potential biomarkers of AF, we analyzed the plasma levels of microRNAs (miR-21, miR-29b, miR-133b, miR-142-5p, miR-150, miR-499, and miR-223-3p) and 13 biochemical biomarkers at admission. The predictive accuracy of biomarkers was assessed by calculating the area under the receiver operating characteristic curve. The data of 117 patients were analyzed (61 with AF, 56 with no AF, 46% men, median age 73 years, median National Institutes of Health Stroke Scale 6). Biochemical biomarkers (N-terminal pro-B-type natriuretic peptide [NT-proBNP], high-sensitivity cardiac troponin I, fibrinogen, C-reactive protein, eGFR, and total triglycerides) were significantly associated with AF. NT-proBNP had the best diagnostic performance for AF with area under the receiver operating characteristic curve 0.92 (95%, CI 0.86-0.98); a cutoff value of >528 ng/L had a sensitivity of 79% and a specificity of 97%. None of the other biomarkers, including microRNAs, was associated with AF. Conventional biochemical biomarkers (NT-proBNP, high-sensitivity cardiac troponin I, fibrinogen, C-reactive protein, eGFR, and triglycerides), but not microRNAs (miR-21, miR-29b, miR-133b, miR-142-5p, miR-150, miR-499, and miR-223-3p) were significantly associated with AF in our ischemic stroke cohort.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a fibrilace síní $x krev $x diagnóza $x genetika $7 D001281
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a biologické markery $x krev $7 D015415
650    12
$a ischemická cévní mozková příhoda $x krev $x diagnóza $7 D000083242
650    12
$a mikro RNA $x krev $7 D035683
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a prospektivní studie $7 D011446
650    _2
$a lidé středního věku $7 D008875
650    _2
$a natriuretický peptid typu B $x krev $7 D020097
650    _2
$a ROC křivka $7 D012372
650    _2
$a peptidové fragmenty $x krev $7 D010446
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a C-reaktivní protein $x analýza $7 D002097
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Kaplan, Vojtěch $u Department of Clinical Biochemistry, Hematology and Immunology, Na Homolce Hospital, Prague, Czech Republic $1 https://orcid.org/0009000216597369
700    1_
$a Šrámková, Tereza $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0009000719691832
700    1_
$a Kolman, Filip $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0009000414590088
700    1_
$a Kloudová, Petra $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0009000918409748
700    1_
$a Benešová, Kateřina $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0009000793698434
700    1_
$a Olšerová, Anna $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000230571387
700    1_
$a Kešnerová, Petra $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000323173791
700    1_
$a Magerová, Hana $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/000900056555245
700    1_
$a Šulc, Vlastimil $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000228153442 $7 xx0200633
700    1_
$a Halmová, Hana $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000234989051
700    1_
$a Kmetonyová, Silvia $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000347653378
700    1_
$a Paulasová-Schwabová, Jaroslava $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000284658269
700    1_
$a Šarbochová, Ivana $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0009000240973600
700    1_
$a Maťoška, Václav $u Department of Clinical Biochemistry, Hematology and Immunology, Na Homolce Hospital, Prague, Czech Republic $1 https://orcid.org/0009000534596193
700    1_
$a Tomek, Aleš $u Department of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital Motol, Prague, Czech Republic $1 https://orcid.org/0000000204494613
773    0_
$w MED00012436 $t Medicine $x 1536-5964 $g Roč. 103, č. 43 (2024), s. e40165
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39470526 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104711 $b ABA008
999    __
$a ok $b bmc $g 2263522 $s 1239800
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 103 $c 43 $d e40165 $e 20241025 $i 1536-5964 $m Medicine $n Medicine (Baltimore) $x MED00012436
GRA    __
$a project No. 618217 $p Charles University Grant Agency (GA UK),
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...